Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 545 of 5804
-
New drug targets 13 cancers in major trial
Disease control Recruiting nowThis study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck squamous cell carcinoma (HNSCC); pancreatic ductal adenocarcinoma (PDAC); colorectal cancer (CRC); hepatocellular carcino…
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Stroke survivors: which statin combo cuts recurrence best?
Disease control Recruiting nowAlong with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever large-vessel ischemic stroke patients treated with clopidogrel assessed through NIHSS, mRS, and possible adverse effects.
Phase: PHASE3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 26, 2026 14:07 UTC
-
New bladder cancer device could delay return of tumors without removing bladder
Disease control OngoingThe purpose of this study is to compare disease free survival (DFS) in participants with recurrence of papillary-only high-risk non-muscle-invasive bladder cancer (HR-NMIBC) within 1 year of last dose of Bacillus Calmette-Guérin (BCG) therapy and who refused or are unfit for Radi…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Hope for women with recurrent pregnancy failure: new drug combo trial
Disease control Recruiting nowA Prospective Randomized Controlled Trial, the goal of this clinical trial is to evaluate the efficacy and safety of doxycycline alone versus doxycycline plus medroxyprogesterone acetate (MPA) in women with chronic endometritis (CE), and to assess subsequent reproductive outcomes…
Phase: NA • Sponsor: Fang Wang • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Lung 'Zapping' procedure could slash severe asthma attacks in Hard-to-Treat patients
Disease control Recruiting nowRationale: For patients with severe asthma that remain uncontrolled with exacerbations despite biologics or patients who are not eligible for biologics, there is no reimbursed treatment other than pulmonary rehabilitation in the Netherlands. Pulmonary rehabilitation is known to h…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Phone-Based fitness program aims to cut heart disease in african american women
Disease control Recruiting nowThe purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.
Phase: PHASE2 • Sponsor: Arizona State University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a bone cement antibiotic stop infections after open leg fractures?
Prevention Recruiting nowThe goal of this randomized clinical trial is to study the best treatment for open lower leg fractures to prevent infection. The main questions it aims to answer is if treating tibia fracture patients with a calcium sulfate antibiotic depot is better at preventing infection that …
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
New program aims to prevent suicide in black teens
Knowledge-focused Recruiting nowThe overall goal of this study is to respond to the urgent need for an effective suicide prevention strategy for Black youth by examining the effectiveness of a systems-level strategy to recognize and respond to suicide risk among Black adolescents who present to emergency depart…
Phase: NA • Sponsor: New York University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New combo pill attack targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis study has as goal to evaluate the use of abemaciclib and bicalutamide in androgen receptor positive metastatic triple negative breast cancer.
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New weekly diabetes shot shows promise in large trial
Disease control CompletedThis is a randomized, open-label, dulaglutide-controlled, multicenter Phase 3 trial to evaluate the efficacy, safety, and immunogenicity of different doses of TG103 injection in combination with metformin in subjects with type 2 diabetes with poor glycemic control treated with me…
Phase: PHASE3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New implant aims to shrink deadly belly aneurysms and prevent rupture
Disease control OngoingTo determine the safety and effectiveness of IMPEDE-FX RapidFill to increase the percentage of subjects with shrinkage of the abdominal aortic aneurysm sac when used as an adjunct to on-label endovascular aneurysm repair (EVAR) stent graft treatment in trial subjects considered c…
Phase: NA • Sponsor: Shape Memory Medical, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a shot clear up acne? new mRNA vaccine trial begins
Disease control Recruiting nowThe purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to four dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a C…
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy aims to deepen remission in multiple myeloma
Disease control Recruiting nowThe goal of this clinical trial is to compare a maintenance therapy consisting of iberdomide and isatuximab with an iberdomide-only regimen. The trial is the subsequent maintenance therapy to GMMG-HD8/DSMM XIX trial for patients with newly-diagnosed multiple myeloma. Patients wit…
Phase: PHASE3 • Sponsor: University of Heidelberg Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Engineered immune cells take on recurrent head and neck cancer
Disease control Recruiting nowThe purpose of this study is to test the safety and tolerability of using a new treatment called autologous T lymphocyte chimeric antigen receptor cells against the CSPG4 antigen (iC9.CAR-CSPG4 T cells) in patients with head and neck cancer that came back after receiving standard…
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for Hard-to-Treat lung cancers: targeted immunotherapy combo tested
Disease control OngoingThe purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy in metastatic NSCLC patients with non-squamous histology who have mutations and/or co-mutations in STK1…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New ointment could ease blistering in rare skin disease
Disease control OngoingThe proposed Phase 2/3 trial with double-blind and open-label extension phases is an international, multicenter study designed to assess the efficacy and safety of diacerein 1% ointment in patients with generalized EBS.
Phase: PHASE2, PHASE3 • Sponsor: TWi Biotechnology, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Simple blood test could spot colon cancer early
Diagnosis Recruiting nowCLIMBED (Colon cancer Liquid biopsy Investigation of Methylation-based Biomarkers Evaluation using Delta-HLD) is a non-randomized, observational, cross-sectional clinical validation study designed to assess the performance of Delta-HLD, Epiliquid's proprietary liquid biopsy techn…
Sponsor: Epiliquid Holding, Inc • Aim: Diagnosis
Last updated Jun 26, 2026 16:39 UTC
-
New heart valve device could spare seniors from Open-Heart surgery
Disease control Recruiting nowThe goal of this clinical trial is to evaluate feasibility, safety, and performance of the SATURN TS TMVR System for the treatment of moderate-to-severe or severe, symptomatic mitral regurgitation through a transcatheter approach. The main questions it aims to answer are: * is t…
Phase: NA • Sponsor: InnovHeart • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New heart procedure aims to tame atrial fibrillation without drugs
Disease control CompletedThis clinical investigation is intended to demonstrate safety and effectiveness of the Volt™ Pulsed Field Ablation (PFA) Catheter Sensor Enabled™, the Volt™ PFA Generator, Agilis™ NxT Steerable Introducer Dual-Reach™, and EnSite™ X EP System EnSite™ Pulsed Field Ablation Module (…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Oral cancer patients may avoid unnecessary radiation to the neck
Disease control Recruiting nowThe present study is a phase II/III prospective randomized trial designed to determine whether eliminating of post operative radiotherapy to regional lymphatics in pN0-N1oral cavity is associated with similar treatment outcomes.
Phase: PHASE2, PHASE3 • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC